On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?

Por Adilson Fonseca Teixeira, Peter ten Dijke, Hong-Jian Zhu
Publicado em 2020-07-01

Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish

Por Jelmer Hoeksma, Gerard C. M. van der Zon, Peter ten Dijke, Jeroen den Hertog
Publicado em 2020-09-01

Correction: Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition.

Por Verena Boschert, Maarten van Dinther, Stella Weidauer, Katharina van Pee, Eva-Maria Muth, Peter ten Dijke, Thomas D. Mueller
Publicado em 2014-01-01

A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

Por Annalisa Addante, Cesáreo Roncero, Nerea Lazcanoiturburu, Rebeca Méndez, Laura Almalé, María García-Álvaro, Peter ten Dijke, Isabel Fabregat, Blanca Herrera, Aránzazu Sánchez
Publicado em 2020-03-01

OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor

Por Chuannan Fan, Qian Wang, Gerard van der Zon, Jiang Ren, Cedrick Agaser, Roderick C. Slieker, Prasanna Vasudevan Iyengar, Hailiang Mei, Peter ten Dijke
Publicado em 2022-04-01

Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10

Por Jingxu Guo, Bin Liu, Midory Thorikay, Minmin Yu, Xiaoyan Li, Zhen Tong, Richard M. Salmon, Randy J. Read, Peter ten Dijke, Nicholas W. Morrell, Wei Li
Publicado em 2022-05-01

Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation

Por Xueyu Chen, Mar Orriols, Frans J. Walther, Frans J. Walther, El Houari Laghmani, Annemarie M. Hoogeboom, Anne C. B. Hogen-Esch, Pieter S. Hiemstra, Gert Folkerts, Marie-José T. H. Goumans, Peter ten Dijke, Nicholas W. Morrell, Gerry T. M. Wagenaar
Publicado em 2017-07-01